Paper40965741
MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer.
Chen X and 9 others. J Cancer Res Clin Oncol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer. Papers, record 40965741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40965741
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Radiation Tolerance | Major topic |
| Humans | |
| Female | |
| Male | |
| Animals | |
| Middle Aged | |
| Mice | |
| Gene Expression Regulation, Neoplastic | |
| Aged | |
| Dendritic Cells | |
| Mice, Nude | |
| Protein Kinase C-delta |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023ZD0502105 | Noncommunicable Chronic Diseases-National Science and Technology Major Project | PubMed | ||
| CSTB2022NSCQ-MSX1356 | Natural Science Foundation of Chongqing | PubMed | ||
| 82172670, 81972858 | National Natural Science Foundation of China | PubMed | ||
| CSTB2022TIAD-KPX0176, 2023DBXM002 | the Technology Innovation and Application Development Project of Chongqing | PubMed | ||
| YXLJ202401 | Chongqing Medical Leading Talent Project | PubMed | ||
| 2024F014 | Clinical Research Special Project of Xinqiao Hospital | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 2 | 15774464 | Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15774464 | PubMed |
| 3 | 31566716 | Long noncoding RNA LINC00657 induced by SP1 contributes to the non-small cell lung cancer progression through targeting miR-26b-5p/COMMD8 axis. | J Cell Physiol | 2020 | https://conductscience.org/library/papers/31566716 | PubMed |
| 4 | 28478231 | Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer. | J Thorac Oncol | 2017 | https://conductscience.org/library/papers/28478231 | PubMed |
| 5 | 36482371 | Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer. | BMC Med | 2022 | https://conductscience.org/library/papers/36482371 | PubMed |
| 6 | 22935141 | A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. | J Mol Cell Biol | 2013 | https://conductscience.org/library/papers/22935141 | PubMed |
| 7 | 22847611 | MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. | Oncogene | 2013 | https://conductscience.org/library/papers/22847611 | PubMed |
| 8 | 2539297 | Radiation sensitivity of human lung cancer cell lines. | Eur J Cancer Clin Oncol | 1989 | https://conductscience.org/library/papers/2539297 | PubMed |
| 9 | 26935060 | miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26935060 | PubMed |
| 10 | 27310702 | Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer. | Br J Cancer | 2016 | https://conductscience.org/library/papers/27310702 | PubMed |
| 11 | 34681719 | The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681719 | PubMed |
| 12 | 39654104 | Comparative analysis of cancer statistics in China and the United States in 2024. | Chin Med J (Engl) | 2024 | https://conductscience.org/library/papers/39654104 | PubMed |
| 13 | 32850333 | Advances in Radiobiology of Stereotactic Ablative Radiotherapy. | Front Oncol | 2020 | https://conductscience.org/library/papers/32850333 | PubMed |
| 14 | 31629410 | Tumor-associated macrophages: an accomplice in solid tumor progression. | J Biomed Sci | 2019 | https://conductscience.org/library/papers/31629410 | PubMed |
| 15 | 34936736 | EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/34936736 | PubMed |
| 16 | 31467405 | Dendritic cells in cancer immunology and immunotherapy. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31467405 | PubMed |
| 17 | 30529041 | Immune mechanisms mediating abscopal effects in radioimmunotherapy. | Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30529041 | PubMed |
| 18 | 38186574 | Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay. | Oncol Res | 2023 | https://conductscience.org/library/papers/38186574 | PubMed |
| 19 | 32476275 | Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32476275 | PubMed |
| 20 | 24982815 | Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer. | Am J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24982815 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42576604 | PRKCD Orchestrates Sevoflurane-Induced Cognitive Dysfunction in Aged Rats by Regulating PINK1/PRKN Mitophagy Pathway. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42576604 | PubMed |
| 41447409 | Nrf2 functions as a biomarker and therapeutic target in lung cancer based on bibliometric analysis and molecular mechanisms. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41447409 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40965741
GET https://conductscience.org/api/papers/v1/40965741/references?page=2